WANBURY Financial Statement Analysis
|
||
|
The Revenues of WANBURY have increased by 3.77% YoY .
The Earnings Per Share (EPS) of WANBURY has decreased by -45.47 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
WANBURY Last 5 Annual Financial Results
[BOM: 524212|NSE : WANBURY]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹600 Cr | ₹578 Cr | ₹500 Cr | ₹511 Cr | ₹393 Cr |
| Expenses | ₹532 Cr | ₹506 Cr | ₹477 Cr | ₹479 Cr | ₹377 Cr |
| Operating Profit (Excl OI) | ₹68 Cr | ₹72 Cr | ₹23 Cr | ₹32 Cr | ₹16 Cr |
| Other Income | ₹12 Cr | ₹0.90 Cr | ₹1.01 Cr | ₹5.09 Cr | ₹4.75 Cr |
| Interest | ₹37 Cr | ₹29 Cr | ₹21 Cr | ₹21 Cr | ₹23 Cr |
| Depreciation | ₹13 Cr | ₹13 Cr | ₹12 Cr | ₹11 Cr | ₹9.75 Cr |
| Profit Before Tax | ₹30 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-12 Cr |
| Profit After Tax | ₹31 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-13 Cr |
| Consolidated Net Profit | ₹31 Cr | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-13 Cr |
| Earnings Per Share (Rs) | ₹9.32 | ₹17.09 | ₹-3.18 | ₹24.94 | ₹-5.04 |
| PAT Margin (%) | 5.06 | 9.60 | -2.04 | 15.83 | -3.20 |
| ROE(%) | 84.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| ROCE(%) | 35.97 | 101.56 | 29.82 | 428.78 | 87.61 |
| Total Debt/Equity(x) | 3.37 | 5.18 | -1.86 | -2.72 | -1.02 |
Key Financials |
||
| Market Cap | : | ₹ 892.0 Cr |
| Revenue (TTM) | : | ₹ 629.8 Cr |
| Net Profit(TTM) | : | ₹ 43.0 Cr |
| EPS (TTM) | : | ₹ 12.3 |
| P/E (TTM) | : | 20.8 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| WANBURY | 2.7% | -9.6% | -8.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 3.5% | -15.1% |
| DIVIS LABORATORIES | 3.1% | -4.8% | 4.9% |
| CIPLA | 1.1% | -4% | -8.5% |
| TORRENT PHARMACEUTICALS | -1.4% | -2.6% | 4.8% |
| DR REDDYS LABORATORIES | -0.4% | -1.1% | -7.8% |
| MANKIND PHARMA | -1.3% | -4.3% | -3.3% |
| ZYDUS LIFESCIENCES | 1.3% | -1.9% | -7.2% |
| LUPIN | 2.7% | 1% | -9.5% |
WANBURY Revenues
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | 3.77 % |
| 5 Yr CAGR | 11.17 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹600 Cr | 3.77 | |
| Mar2024 | ₹578 Cr | 15.63 | |
| Mar2023 | ₹500 Cr | -2.26 | |
| Mar2022 | ₹511 Cr | 30.23 | |
| Mar2021 | ₹393 Cr | - | |
WANBURY Operating Profit
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | -6.10 % |
| 5 Yr CAGR | 44.17 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹68 Cr | -6.10 | |
| Mar2024 | ₹72 Cr | 212.39 | |
| Mar2023 | ₹23 Cr | -27.28 | |
| Mar2022 | ₹32 Cr | 102.52 | |
| Mar2021 | ₹16 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -9.54 % |
| 5 Yr CAGR | 29.70 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 11.29% | -9.54 | |
| Mar2024 | 12.48% | 170.13 | |
| Mar2023 | 4.62% | -25.60 | |
| Mar2022 | 6.21% | 55.64 | |
| Mar2021 | 3.99% | - | |
WANBURY Profit After Tax
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | -45.44 % |
| 5 Yr CAGR | Positive |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹31 Cr | -45.44 | |
| Mar2024 | ₹56 Cr | Positive | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹81 Cr | Positive | |
| Mar2021 | ₹-13 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -47.29 % |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 5.06 % | -47.29 | |
| Mar2024 | 9.6 % | Positive | |
| Mar2023 | -2.04 % | Negative | |
| Mar2022 | 15.83 % | Positive | |
| Mar2021 | -3.2 % | - | |
WANBURY Earnings Per Share (EPS)
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | -45.47 % |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.32 | -45.47 | |
| Mar2024 | ₹17 | Positive | |
| Mar2023 | ₹-3.18 | Negative | |
| Mar2022 | ₹25 | Positive | |
| Mar2021 | ₹-5.04 | - | |
WANBURY Return on Capital Employed (ROCE)
[BOM: 524212|NSE : WANBURY]
| Y-o-Y | -64.58 % |
| 5 Yr CAGR | -19.95 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 35.97% | -64.58 | |
| Mar2024 | 101.56% | 240.58 | |
| Mar2023 | 29.82% | -93.05 | |
| Mar2022 | 428.78% | 389.42 | |
| Mar2021 | 87.61% | - | |
WANBURY Share Price vs Sensex
| Current Share Price | : | ₹255.6 |
| Current MarketCap | : | ₹ 892.0 Cr |
| Updated EOD on | : | Oct 06,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | 2.7% |
-9.6% |
-8.7% |
| SENSEX | 1.7% |
1.5% |
-3% |
WANBURY related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 2.2% | -0.6% | -0.6% |
| BSE SMALLCAP | 1.9% | 0.5% | -6.8% |
No NSE index found
You may also like the below Video Courses
FAQ about WANBURY Financials
How the annual revenues of WANBURY have changed ?
The Revenues of WANBURY have increased by 3.77% YoY .
How the Earnings per Share (EPS) of WANBURY have changed?
The Earnings Per Share (EPS) of WANBURY has decreased by -45.47 % YoY .
Check out Intrinsic Value of Peers of WANBURY
Compare Stock Analytics of Peers of WANBURY
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
